BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate Merger Agreement
Posted on November 30, 2012 at 06:13 AM EST
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) and privately held Presidio Pharmaceuticals, Inc. today announced the mutual termination of the Merger Agreement and the related Investor Financing Agreement entered into on October 17, 2012. Although